Emergent Biosolutions reported $151.6M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
ALKERMES ALKS:US 223.39M 47.4M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amarin AMRN:US $ 72.39M 41.46M
Ani Pharmaceuticals ANIP:US $ 30.21M 3.18M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Emergent Biosolutions EBS:US $ 151.6M 358.7M
Exact Sciences EXAS:US $ 351.87M 2.89M
Exelixis EXEL:US $ 342.78M 95.45M
Glaxosmithkline GSK:US $ 6135M 283M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
IONIS PHARMACEUT IONS:US $ 438M 307.99M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Lonza Group LONN:SW 1.07B 24M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Myriad Genetics MYGN:US $ 115M 4.5M
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Opko Health OPK:US $ 85.34M 23.16M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Pfizer PFE:US $ 15651M 1516M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M
United Therapeutics UTHR:US $ 436M 55.4M